Skip to main content

3 July 2026

Last updated: Friday 3 July 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Commentary: The outlook for biotech seems rosy - for now

Monday 17 February 2014

Interviewee/Contributor

Robin Davison

Organisation

Edison Investment Research Ltd

Financial thermometer rises at JP Morgan meeting

Wednesday 10 February 2010

Interviewee/Contributor

Robin Davison

Organisation

Edison Investment Research

Pagination

First page
Previous page
Page 1
Page 2
Current page 3

Organisations

Forbion
Auspherix Ltd
RhoVac AB
Lead Pharma BV
Progenitor Labs Ltd
Medigene AG
Seventure Partners
Medherant Ltd
Pharming Group NV
MedNous editorial board

Interviewees and Contributers

Olav Hellebø
Eliot Forster
Thomas Lönngren
Johan Strömquist
Gabriel Festoc
Michael Salgaller, Michele Newton and Michael Pollack
Eric Olson
Adam Steensberg
Gil Beyen
Francesco De Rubertis

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Evotec names head of in silico and AI

Saturday 20 June 2026

Forbion promotes senior officers, appoints operating partner

Saturday 20 June 2026

Specialist CDMO Ardena appoints CSO

Saturday 20 June 2026

CellaVision names CEO

Saturday 20 June 2026

FundaMental Pharma names CMO to lead depression candidate

Saturday 20 June 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form